Global Oxytocic Pharmaceuticals Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Oxytocic Pharmaceuticals Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Available under the brand name of Pitocin, the drug oxytocin, which is derived from the peptide of the same name, is commonly used on women during childbirth in order to induce contractions. This can not only increase labor speeds and reduce the time taken for childbirth, but can also cease bleeding after delivery. It is almost always administered to a patient by injecting it into their vein or muscle.
Oxytocic Pharmaceuticals report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oxytocic Pharmaceuticals market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Abortion Induced Incomplete and Inevitable Abortion are the major drivers for the industry.
The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oxytocic Pharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Fresenius Kaci
Biofutura
Baxter
Pfizer
Ferring
Novartis
Teva
Segment by Type
Natural Oxytocin
Synthetic Oxytocin Derivative
Abortion Induced Incomplete
Inevitable Abortion
Post-partum Haemorrhage
Labour Induction
Labour Arrest
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oxytocic Pharmaceuticals market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oxytocic Pharmaceuticals, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oxytocic Pharmaceuticals industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oxytocic Pharmaceuticals in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oxytocic Pharmaceuticals introduction, etc. Oxytocic Pharmaceuticals Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oxytocic Pharmaceuticals market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Oxytocic Pharmaceuticals report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oxytocic Pharmaceuticals market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Abortion Induced Incomplete and Inevitable Abortion are the major drivers for the industry.
The post-partum haemorrhage segment is expected to register high Y-o-Y growth during the forecast period and is projected to remain the dominant segment during the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oxytocic Pharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Fresenius Kaci
Biofutura
Baxter
Pfizer
Ferring
Novartis
Teva
Segment by Type
Natural Oxytocin
Synthetic Oxytocin Derivative
Segment by Application
Abortion Induced Incomplete
Inevitable Abortion
Post-partum Haemorrhage
Labour Induction
Labour Arrest
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oxytocic Pharmaceuticals market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oxytocic Pharmaceuticals, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oxytocic Pharmaceuticals industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oxytocic Pharmaceuticals in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oxytocic Pharmaceuticals introduction, etc. Oxytocic Pharmaceuticals Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oxytocic Pharmaceuticals market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices